Sailer V, Schiffman MH, Kossai M, Cyrta J, Beg S, Sullivan B, Pua BB, Lee KSteve, Talenfeld AD, Nanus DM et al..
2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.. Cancer. 124(5):1008-1015.
Do KTrinh, Wahl S, Raffler J, Molnos S, Laimighofer M, Adamski J, Suhre K, Strauch K, Peters A, Gieger C et al..
2018.
Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies.. Metabolomics. 14(10):128.
McNair C, Xu K, Mandigo AC, Benelli M, Leiby B, Rodrigues D, Lindberg J, Gronberg H, Crespo M, De Laere B et al..
2018.
Differential impact of RB status on E2F1 reprogramming in human cancer.. J Clin Invest. 128(1):341-358.
Hertel J, Rotter M, Frenzel S, Zacharias HU, Krumsiek J, Rathkolb B, de Angelis MHrabe, Rabstein S, Pallapies D, Brüning T et al..
2018.
Dilution correction for dynamically influenced urinary analyte data.. Anal Chim Acta. 1032:18-31.
Thirumavalavan N, Scovell JM, Link RE, Lamb DJ, Lipshultz LI.
2018.
Does Solid Organ Transplantation Affect Male Reproduction? Eur Urol Focus. 4(3):307-310.
Rickman DS, Schulte JH, Eilers M.
2018.
The Expanding World of N-MYC-Driven Tumors.. Cancer Discov. 8(2):150-163.
Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, Chatila WK, Chakravarty D, G Han C, Coleman I et al..
2018.
The long tail of oncogenic drivers in prostate cancer.. Nat Genet. 50(5):645-651.
Arora K, Barbieri CE.
2018.
Molecular Subtypes of Prostate Cancer.. Curr Oncol Rep. 20(8):58.
Lundquist MR, Goncalves MD, Loughran RM, Possik E, Vijayaraghavan T, Yang A, Pauli C, Ravi A, Verma A, Yang Z et al..
2018.
Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.. Mol Cell. 70(3):531-544.e9.
Nötzel C, Poran A, Kafsack BFC.
2018.
Single-Cell Transcriptome Profiling of Protozoan and Metazoan Parasites.. Trends Parasitol. 34(9):731-734.
Desai P, Mencia-Trinchant N, Savenkov O, Simon MS, Cheang G, Lee S, Samuel M, Ritchie EK, Guzman ML, Ballman KV et al..
2018.
Somatic mutations precede acute myeloid leukemia years before diagnosis.. Nat Med. 24(7):1015-1023.
Shoag J, Liu D, Blattner M, Sboner A, Park K, Deonarine L, Robinson BD, Mosquera JMiguel, Chen Y, Rubin MA et al..
2018.
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.. J Clin Invest. 128(1):381-386.
Boysen G, Rodrigues DN, Rescigno P, Seed G, Dolling D, Riisnaes R, Crespo M, Zafeiriou Z, Sumanasuriya S, Bianchini D et al..
2018.
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity.. Clin Cancer Res. 24(22):5585-5593.
Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR et al..
2018.
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.. Nature. 560(7719):499-503.
Herder C, Kannenberg JM, Carstensen-Kirberg M, Strom A, Bönhof GJ, Rathmann W, Huth C, Koenig W, Heier M, Krumsiek J et al..
2018.
A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study.. Diabetes. 67(11):2434-2442.